Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
Boston, United States
Countries of investment
  • USA
  • United Kingdom
  • Switzerland
  • Canada
  • Germany
  • France
  • Italy
  • Spain
  • Belgium
  • Netherlands
  • Austria
  • Luxembourg
  • Sweden
  • Denmark
  • Ireland
  • Norway
  • Finland
  • Portugal
  • Greece
  • Malta
  • Liechtenstein
  • Monaco
  • San Marino
  • Andorra
Investment stages
  • Seed
  • Series A
  • Series B
  • Series C
Industries
  • Pharma
  • Consumer Products
  • Diagnostics
  • Medical Devices
  • Service
About
A New York-based healthcare investment firm founded in 2000. Aisling Capital focuses on innovative healthcare products, pharmaceutical and biotech solutions, and medical technologies. With over $1.8 billion raised across four funds and a team of seasoned professionals, they back both private and public-stage companies with deep clinical and financial expertise.
Min check size
$10M
Max check size
$50M
Fund size
NPS

Investment Thesis

Aisling Capital invests in high-growth companies primarily in the United States and Western Europe. The firm targets founders building market-leading technology businesses with a focus on scalable innovation and strategic growth.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Aisling Capital invests in transformative healthcare companies across biopharma, medical devices, diagnostics, and digital health. They work with innovative entrepreneurs to bring impactful solutions to patients and healthcare systems globally, combining deep life sciences expertise with strategic support.

Aisling Capital Contacts Information

Primary contact

Secondary contact

Portfolio

Aclaris Therapeutics

Inc.

Adams Respiratory Therapeutics

Inc.

ADMA Biologics

Inc.

Advion

Inc.

Aeglea BioTherapeutics

Inc.

Agile Therapeutics

Inc.

Aimmune Therapeutics

Inc.

Ajax Health

Allos Therapeutics

Inc.

Ambit Biosciences Corporation

Antios Therapeutics

Aragon Pharmaceuticals

Inc.

Archimica Cooperatief U.A.

Arcus Biosciences

Inc.

ARMGO Pharma

Inc.

ARMO BioSciences

Inc.

Ascendis Pharma A/S

Aton Pharma

Inc.

Atreca

Inc.

Audentes Therapeutics

Inc.

Auxilium Pharmaceuticals

Inc.

AVANZA Laboratories

LLC

AVROBIO

Inc.

Axcan Pharma

Inc.

Barrier Therapeutics

Inc.

Bicara Therapeutics

Bioenvision

Inc.

Biohaven Pharmaceuticals Ltd.

Biomea Fusion

Inc.

BridgeBio Pharma LLC

CalciMedica

Inc.

Cardiokine

Inc.

Catalent

Inc.

Cempra

Inc.

Chimerix

Inc.

Cidara Therapeutics

Inc.

Clovis Oncology

Inc.

CollaGenex Pharmaceuticals

Inc.

Colorescience

Inc.

COMPASS Pathways

Cynapsus Therapeutics Inc.

Cytos Biotechnology AG

Dermira

Inc.

Dren Bio

Durata Therapeutics

Inc.

EarLens Corporation

Eidos Therapeutics

Elevation Oncology

Inc.

Esperion Therapeutics

Inc.

F2G Limited

Forge Biologics

Garuda Therapeutics

Inc.

Global Blood Therapeutics

Inc.

GTx

Inc.

Harmony Biosciences

LLC

Ibrutinib Royalty

Infinity Pharmaceuticals

Inc.

Intercept Pharmaceuticals

Inc.

Intersect ENT

Inc.

LENSAR

Inc.

Lombard Medical

Inc.

Loxo Oncology

Inc.

MAP Pharmaceuticals

Inc.

Marker Therapeutics

Inc.

MKG LLC

MEI Pharma

Inc.

Menlo Therapeutics Inc.

Mindful Health Solutions

Miramar Labs

Inc.

Monte Rosa Therapeutics

Inc.

Myogen

Inc.

Nabriva

NextWave Pharmaceuticals

Inc.

Novazyme Pharmaceuticals

Inc.

Nuvation Bio

Inc.

ObsEva SA

Oculex Pharmaceuticals

Inc.

Paratek Pharmaceuticals

Inc.

PellePharm

Pernix Therapeutics

Inc.

Pharmaron

Inc.

Planet Biopharmaceuticals

Inc.

Poseida Therapeutics

Inc.

PowerVision

Inc.

PreCision Dermatology

Inc.

Prolacta Bioscience

Inc.

Promentis Pharmaceuticals

Inc.

Protagonist Therapeutics

Inc.

Quintiles Transnational Holdings Inc.

Reneo Pharmaceuticals

Inc.

Roka Bioscience

Inc.

Seragon Pharmaceuticals

Inc.

Sirion Therapeutics

Inc.

SkinMedica

Inc.

Sorrento Therapeutics

Inc.

Spirox

Inc.

Spruce Biosciences

Spyre Therapeutics

Syndax Pharmaceuticals

Inc.

Synergy Pharmaceuticals Inc.

Syros Pharmaceuticals

Inc.

T2 Biosystems

Inc.

Talaris Therapeutics

Inc.

Topaz Pharmaceuticals

Inc.

TransEnterix

Inc.

Treeline Biosciences

Inc.

TRIA Beauty

Inc.

Verona Pharma plc

Versartis

Inc.

ViewRay

Inc.

Viracta Pharmaceuticals

Inc.

VIVUS

Inc.

Wugen

Inc.

Zavante Therapeutics

Inc.

ZELTIQ Aesthetics

Inc.

Zosano Pharma Corporation

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp